Adenovirus-mediated viral interleukin-10 gene transfer prevents concanavalin A-induced liver injury

Digestive and Liver Disease

Volumn 44, Issue 5, 2012, Pages 398-405

  Zhou, Yan Chun ^a   Chen, Sui ^a   Cao, Jun Jun ^a   Chen, Shao Ying ^a   Xie, Yan Fei ^a   Niu, Qing Xia ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Hepatitis; Hepatoprotection; Inflammatory cytokines; Viral IL 10

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 10;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOCOMPETENT CELL; LIVER INJURY; LIVER PROTECTION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CONCANAVALIN A; DOWN-REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LIVER; LIVER FAILURE, ACUTE; MICE; MICE, INBRED C57BL; MITOGENS; MONOCYTES; T-LYMPHOCYTES;

EID: 84859219041     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.11.013     Document Type: Article

References (42)

1. Ichiki Y., Aoki C.A., Bowlus C.L., et al. T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005, 4:315-321.
2. Moebius U., Manns M., Hess G., et al. T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol 1990, 20:889-896.
3. Odashima M., Otaka M., Jin M., et al. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice. Biochem Biophys Res Commun 2006, 347:949-954.
4. Yin H., Cheng L., Agarwal C., et al. Lactoferrin protects against concanavalin A-induced liver injury in mice. Liver Int 2010, 30:623-632.
5. Kremer M., Perry A.W., Milton R.J., et al. Pivotal role of Smad3 in a mouse model of T cell-mediated hepatitis. Hepatology 2008, 47:113-126.
6. Nicoletti F., Zaccone P., Xiang M., et al. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. Cytokine 2000, 12:315-323.
7. Toyabe S., Seki S., Iiai T., et al. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 1997, 159:1537-1542.
8. Di Marco R., Xiang M., Zaccone P., et al. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. Autoimmunity 1999, 31:75-83.
9. Kato M., Ikeda N., Matsushita E., et al. Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by concanavalin A. Hepatol Res 2001, 20:232-243.
10. de Waal Malefyt R., Haanen J., Spits H., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991, 174:915-924.
11. Slobedman B., Barry P.A., Spencer J.V., et al. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol 2009, 83:9618-9629.
12. Hsu D.H., de Waal Malefyt R., Fiorentino D.F., et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990, 250:830-832.
13. Ding Y., Qin L., Kotenko S.V., et al. A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med 2000, 191:213-224.
14. Zhang N., Cui H.D., Xue H.X. Effect of local viral transfer of interleukin 10 gene on a rabbit arthritis model induced by interleukin 1beta. Chin Med J 2008, 121:435-438.
15. Yang Z., Chen M., Wu R., et al. Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol 2002, 168:6479-6485.
16. Smith J.R., Verwaerde C., Rolling F., et al. Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Hum Gene Ther 2005, 16:1037-1046.
17. Shen J., Taylor N., Duncan L., et al. Ex vivo adenovirus mediated gene transfection of human conjunctival epithelium. Br J Ophthalmol 2001, 85:861-867.
18. Brough D.E., Hsu C., Kulesa V.A., et al. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J Virol 1997, 71:9206-9213.
19. Mittereder N., March K.L., Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996, 70:7498-7509.
20. Hathcock K.S. T cell enrichment by nonadherence to nylon. Curr Protoc Immunol 1992, 85:3.2.1-3.2.4.
21. Li B., Sun R., Wei H., et al. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 2006, 43:1211-1219.
22. Niu Q., Zhao C., Jing Z. An evaluation of the colorimetric assays based on enzymatic reactions used in the measurement of human natural cytotoxicity. J Immunol Methods 2001, 251:11-19.
23. Sternak M., Khomich T.I., Jakubowski A., et al. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse. Pharmacol Rep 2010, 2:483-493.
24. Lan L., Chen Y., Sun C., et al. Transplantation of bone marrow-derived hepatocyte stem cells transduced with adenovirus-mediated IL-10 gene reverses liver fibrosis in rats. Transpl Int 2008, 21:581-592.
25. Li L., Huang J.L., Liu Q.C., et al. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery. World J Gastroenterol 2004, 10:1867-1871.
26. Jiang G.P., Hu Z.H., Zheng S.S., et al. Adenovirus mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation. World J Gastroenterol 2005, 11:1065-1069.
27. Appledorn D.M., Patial S., McBride A., et al. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol 2008, 181:2134-2144.
28. Hsu C.Y., Liu H.E., Sheu F.Y., et al. Synergistic therapeutic effects of combined adenovirus-mediated interleukin-10 and interleukin-12 gene therapy on airway inflammation in asthmatic mice. J Gene Med 2010, 12:11-21.
29. Bai R.Z., Wu Y., Liu Q., et al. Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin. J Exp Clin Cancer Res 2009, 28:31-39.
30. Chen C.R., Pichurin P., Chazenbalk G.D., et al. Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease. Endocrinology 2004, 145:228-233.
31. Atta H.M., Al-Hendy A., Salama S.A., et al. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation. Liver Int 2009, 29:1022-1030.
32. Oberholzer C., Oberholzer A., Tschoeke S.K., et al. Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expression. J Endotoxin Res 2004, 10:393-401.
33. Bonder C.S., Ajuebor M.N., Zbytnuik L.D., et al. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 2004, 172:45-53.
34. Feng D., Mei Y., Wang Y., et al. Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation. Immunol Lett 2008, 121:127-133.
35. Wang Z.L., Wu X.H., Song L.F., et al. Phosphoinositide 3-kinase gamma inhibitor ameliorates concanavalin A-induced hepatic injury in mice. Biochem Biophys Res Commun 2009, 386:569-574.
36. Ferreyra Solari N.E., Galoppo C., Cuarterolo M., et al. The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis. Clin Immunol 2010, 137:396-405.
37. al-Janadi M., al-Wabel A., Raziuddin S. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin Immunol Immunopathol 1994, 71:33-37.
38. Ye F., Yan S., Xu L., et al. Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis. Immunol Lett 2009, 122:198-207.
39. Yamashita J., Iwamura C., Sasaki T., et al. Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function. J Immunol 2011, 186:3410-3420.
40. Nachtwey J., Spencer J.V. HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB. Viral Immunol 2008, 21:477-482.
41. Pan H., Hong F., Radaeva S., et al. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 2004, 1:43-49.
42. Carter J.D., Ellett J.D., Chen M., et al. Viral IL-10-mediated immune regulation in pancreatic islet transplantation. Mol Ther 2005, 12:360-368.